Sun Pharma acquires US-based Pharmalucence

Sun Pharmaceutical Industries Ltd BSE 0.85 %, India's third-largest generic drugmaker by sales, said on Wednesday it had acquired US-based Pharmalucence Inc, which has sterile injectable capacity and research capabilities.